Birgitte Volck
Director/Board Member chez SOLENO THERAPEUTICS, INC.
Fortune : 301 526 $ au 31/03/2024
Profil
Actuellement, Birgitte Volck occupe le poste de SVP, responsable du développement clinique et des affaires médicales chez Ascendis Pharma A. Le Dr Volck est également membre du conseil d'administration de Soleno Therapeutics, Inc. et de Vaccibody AS. Auparavant, le Dr Volck a occupé les postes de chef de la recherche et du développement chez GlaxoSmithKline Plc, de directeur médical et de premier vice-président du développement chez Swedish Orphan Biovitrum AB, de président de la recherche et du développement chez Avrobio, Inc, de directeur du développement exécutif chez Amgen, Inc, de directeur médical nordique et de directeur de projet chez Genzyme Danmark et de chef du développement clinique et des affaires médicales chez Pharmexa A. Birgitte Volck a obtenu un doctorat de l'université de Copenhague.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0,02% | 26/05/2023 | 7 045 ( 0,02% ) | 301 526 $ | 31/03/2024 |
Postes actifs de Birgitte Volck
| Sociétés | Poste | Début |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 10/06/2019 |
| NYKODE THERAPEUTICS | Director/Board Member | 05/05/2021 |
Anciens postes connus de Birgitte Volck
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01/12/2023 |
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 01/01/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/08/2018 |
| WILSON THERAPEUTICS AB | Director/Board Member | 01/05/2018 |
Formation de Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
| Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
